Table 3.
Side effects reported as moderate or severe by over 5% of participants on Day 10 of either medication period.
| Side effect | Participants rating side effect as moderate or severe at Day 10 of: | P | |||
|---|---|---|---|---|---|
| Varenicline | Placebo | ||||
| N | % | N | % | ||
| Dry mouth | 15 | 22.4 | 6 | 9.0 | .035 |
| Abnormal dreams | 14 | 20.9 | 2 | 3.0 | .004 |
| Increased flatulence | 14 | 20.9 | 9 | 13.4 | .18 |
| Fatigue | 10 | 14.9 | 5 | 7.5 | .18 |
| Nausea | 10 | 14.9 | 1 | 1.5 | .004 |
| Reflux | 10 | 14.9 | 1 | 1.5 | .004 |
| Sleep disorder | 8 | 11.9 | 2 | 3.0 | .07 |
| Insomnia | 7 | 10.4 | 6 | 9.0 | 1.00 |
| Abdominal pain | 6 | 9.0 | 2 | 3.0 | .22 |
| Constipation | 6 | 9.0 | 0 | 0.0 | .031 |
| Stomach pain | 5 | 7.5 | 0 | 0.0 | .06 |
| Headache | 4 | 6.0 | 3 | 4.5 | 1.00 |
| Taste problems | 4 | 6.0 | 2 | 3.0 | .69 |
Note. P-values are for McNemar tests comparing varenicline to placebo.